PortfoliosLab logoPortfoliosLab logo
TWST vs. EVC
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

TWST vs. EVC - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Twist Bioscience Corporation (TWST) and Entravision Communications Corporation (EVC). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, TWST achieves a 187.61% return, which is significantly lower than EVC's 266.73% return.


TWST

1D
-1.49%
1M
7.39%
6M
121.06%
YTD
187.61%
1Y
148.65%
3Y*
55.70%
5Y*
-4.04%
10Y*

EVC

1D
-5.06%
1M
14.99%
6M
218.85%
YTD
266.73%
1Y
350.71%
3Y*
41.86%
5Y*
18.86%
10Y*
9.08%
*Multi-year figures are annualized to reflect compound growth (CAGR)

TWST vs. EVC - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
TWST
Twist Bioscience Corporation
187.61%-31.74%26.07%54.81%-69.23%-45.23%572.81%-9.05%77.62%
EVC
Entravision Communications Corporation
266.73%35.80%-37.56%-9.16%-27.83%151.06%12.21%-3.93%-38.32%

Correlation

The correlation between TWST and EVC is 0.25, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.25

Correlation (3Y)
Calculated over the trailing 3-year period

0.29

Correlation (5Y)
Calculated over the trailing 5-year period

0.33

Correlation (All Time)
Calculated using the full available price history since Oct 31, 2018

0.25

Fundamentals

Market Cap

TWST:

$5.68B

EVC:

$967.33M

EPS

TWST:

-$1.33

EVC:

-$0.19

PS Ratio

TWST:

13.61

EVC:

1.77

PB Ratio

TWST:

12.37

EVC:

15.60

Total Revenue (TTM)

TWST:

$409.48M

EVC:

$552.71M

Gross Profit (TTM)

TWST:

$213.23M

EVC:

$166.48M

EBITDA (TTM)

TWST:

-$58.23M

EVC:

$68.21M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TWST vs. EVC — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TWST
TWST Risk / Return Rank: 9090
Overall Rank
TWST Sharpe Ratio Rank: 9393
Sharpe Ratio Rank
TWST Sortino Ratio Rank: 8989
Sortino Ratio Rank
TWST Omega Ratio Rank: 8585
Omega Ratio Rank
TWST Calmar Ratio Rank: 9393
Calmar Ratio Rank
TWST Martin Ratio Rank: 9090
Martin Ratio Rank

EVC
EVC Risk / Return Rank: 9898
Overall Rank
EVC Sharpe Ratio Rank: 9797
Sharpe Ratio Rank
EVC Sortino Ratio Rank: 9999
Sortino Ratio Rank
EVC Omega Ratio Rank: 9898
Omega Ratio Rank
EVC Calmar Ratio Rank: 9999
Calmar Ratio Rank
EVC Martin Ratio Rank: 9999
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TWST vs. EVC - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Twist Bioscience Corporation (TWST) and Entravision Communications Corporation (EVC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


TWSTEVCDifference
Sharpe ratioReturn per unit of total volatility

-0.74

Sortino ratioReturn per unit of downside risk

-3.06

Omega ratioGain probability vs. loss probability

1.31

1.70

-0.38

Calmar ratioReturn relative to maximum drawdown

4.42

15.03

-10.61

Martin ratioReturn relative to average drawdown

9.92

37.01

-27.09

TWST vs. EVC - Sharpe Ratio Comparison

The current TWST Sharpe Ratio is 2.21, which is comparable to the EVC Sharpe Ratio of 2.95. The chart below compares the historical Sharpe Ratios of TWST and EVC, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

TWST vs. EVC - Drawdown Comparison

The maximum TWST drawdown since its inception was -94.48%, roughly equal to the maximum EVC drawdown of -99.26%. Use the drawdown chart below to compare losses from any high point for TWST and EVC.


Loading charts...

Drawdown Indicators


TWSTEVCDifference

Max Drawdown

Largest peak-to-trough decline

-94.48%

-99.26%

+4.78%

Max Drawdown (1Y)

Largest decline over 1 year

-33.86%

-23.52%

-10.34%

Max Drawdown (3Y)

Largest decline over 3 years

-58.97%

-69.65%

+10.68%

Max Drawdown (5Y)

Largest decline over 5 years

-91.54%

-83.43%

-8.11%

Max Drawdown (10Y)

Largest decline over 10 years

-83.43%

Current Drawdown

Current decline from peak

-56.13%

-22.03%

-34.10%

Average Drawdown

Average peak-to-trough decline

-58.12%

-67.40%

+9.28%

Ulcer Index

Depth and duration of drawdowns from previous peaks

15.24%

9.57%

+5.67%

Volatility

TWST vs. EVC - Volatility Comparison

The current volatility for Twist Bioscience Corporation (TWST) is 18.33%, while Entravision Communications Corporation (EVC) has a volatility of 21.93%. This indicates that TWST experiences smaller price fluctuations and is considered to be less risky than EVC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


TWSTEVCDifference

Volatility (1M)

Calculated over the trailing 1-month period

18.33%

21.93%

-3.60%

Volatility (6M)

Calculated over the trailing 6-month period

48.52%

83.81%

-35.29%

Volatility (1Y)

Calculated over the trailing 1-year period

67.63%

119.84%

-52.21%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

76.08%

74.27%

+1.81%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

78.27%

65.48%

+12.79%

Dividends

TWST vs. EVC - Dividend Comparison

TWST has not paid dividends to shareholders, while EVC's dividend yield for the trailing twelve months is around 1.90%.


PositionTTM20252024202320222021202020192018201720162015
EVC
Entravision Communications Corporation
1.90%6.83%8.51%4.80%2.08%1.47%4.55%7.63%6.87%2.27%1.79%1.38%
TWST
Twist Bioscience Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

TWST vs. EVC - Financials Comparison

This section allows you to compare key financial metrics between Twist Bioscience Corporation and Entravision Communications Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00M250.00M300.00M350.00MJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
110.72M
196.97M
(TWST) Total Revenue
(EVC) Total Revenue
Values in USD except per share items

TWST vs. EVC - Profitability Comparison

The chart below illustrates the profitability comparison between Twist Bioscience Corporation and Entravision Communications Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

10.0%20.0%30.0%40.0%50.0%JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
51.6%
48.2%
Portfolio components
TWST - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Twist Bioscience Corporation reported a gross profit of 57.12M and revenue of 110.72M. Therefore, the gross margin over that period was 51.6%.

EVC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Entravision Communications Corporation reported a gross profit of 95.02M and revenue of 196.97M. Therefore, the gross margin over that period was 48.2%.

TWST - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Twist Bioscience Corporation reported an operating income of -45.86M and revenue of 110.72M, resulting in an operating margin of -41.4%.

EVC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Entravision Communications Corporation reported an operating income of 20.69M and revenue of 196.97M, resulting in an operating margin of 10.5%.

TWST - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Twist Bioscience Corporation reported a net income of -44.02M and revenue of 110.72M, resulting in a net margin of -39.8%.

EVC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Entravision Communications Corporation reported a net income of 12.36M and revenue of 196.97M, resulting in a net margin of 6.3%.


Frequently Asked Questions


TWST and EVC have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

EVC has higher volatility (21.93%) compared to TWST (18.33%). In terms of maximum drawdown, TWST dropped -94.48% vs EVC's -99.26%.

EVC currently has the higher Sharpe Ratio (2.95 vs 2.21), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for TWST and EVC

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer